Ozempic or Your Own GLP-1? What a Morning Walk Taught Me

This morning I went for a walk with a woman I recently met. She is in her 70s — funny, active, full of stories from a vividly lived life. She is less than ten years older than me, and I adore her company.

She is also carrying atrial fibrillation, high cholesterol, pre-diabetes, extra weight, and arthritis. As she talked, my mind quietly lit up: metabolic disease. Every one of those diagnoses is a branch off the same root.

She mentioned her doctor had offered her Ozempic. I gently shared that her body already makes GLP-1 — the very hormone the drug mimics — and that with a few lifestyle shifts she could produce more of her own, feel remarkable, and skip the weekly injection entirely.

She waved me off. Insurance would cover it. A shot is easy.

I understand. Truly. But I want to tell you what I wish I had a longer walk to say.

What Ozempic Actually Does

Ozempic (semaglutide) is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after meals to slow digestion, quiet appetite, and steady blood sugar. The drug is a synthetic key that fits the same lock — louder, longer, and administered from the outside.

That external signal works. But it works instead of, not alongside, your own biology. And that distinction matters more than the marketing lets on.

What We Still Don't Know

The honest picture from current research:

• Modest long-term results. Even after extended use, only a fraction of users reach a healthy body weight. Most remain overweight or obese. Long-term effectiveness after discontinuation is largely unknown — and weight regain is common when the drug stops.
• Side effects. GI issues (nausea, vomiting) are the everyday complaint. Rarer but more serious: pancreatitis, kidney and gallbladder problems, and muscle loss. (A quick tip: anything ending in "-itis" means inflammation.) Observational studies have also linked semaglutide to increased risk of nonarteritic anterior ischemic optic neuropathy — a form of vision loss — though causality is not fully established.
• Regulatory concerns. The FDA has raised questions about Novo Nordisk's reporting of serious adverse events, including deaths, strokes, and suicidal ideation — pointing to gaps in how risks are monitored and communicated.
• Ethical and societal questions. High cost, lifelong dependence, and limited access raise real concerns about fairness and about over-relying on a pharmaceutical answer to what is fundamentally a lifestyle-and-environment problem.
• Mechanistic unknowns. The full long-term effects on metabolism, cardiovascular health, and other organ systems are not completely understood. We are, collectively, in year one of a very long experiment.

None of this means Ozempic is never the right tool. It means it is not a shortcut around the work — it is a different, heavier trade.

Muscle Loss Is the Quiet Cost

The one I want you to hear loudest is muscle loss. Studies suggest that up to 40% of weight lost on GLP-1 drugs is lean mass — muscle and bone. In your 70s, muscle is not vanity. It is:

• your defense against falls and fractures
• your largest site of glucose disposal (so, your best insulin sensitizer)
• your metabolic engine, quite literally
• the tissue that keeps you doing the things you love

Losing weight while losing muscle is not the same as getting healthier. It can quietly accelerate frailty even as the scale rewards you.

Your Body Already Makes GLP-1

Here is the piece most people never hear: your gut secretes GLP-1 in response to specific inputs. You can turn that dial up — meaningfully — with lifestyle. Not with willpower. With signals.

Lifestyle Signal	Why It Raises Your Own GLP-1
Protein at every meal	Amino acids are the strongest natural GLP-1 trigger
Fiber (30+ g/day)	Feeds gut bacteria that produce short-chain fatty acids, which stimulate GLP-1
Fermented foods	Kefir, kimchi, sauerkraut, yogurt shift the microbiome toward GLP-1 producers
Bitter foods & greens	Activate bitter receptors in the gut that trigger GLP-1 release
Walking after meals	Improves glucose disposal and enhances the post-meal GLP-1 curve
Sleep 7–9 hours	Poor sleep blunts GLP-1 and raises hunger hormones the next day
Nervous system regulation	Chronic stress suppresses GLP-1 signaling and drives cravings

None of these are exotic. None require a prescription. They just require a coach and a plan — and someone walking alongside you.

Why I Built Live Light Hearted

I keep thinking about my friend on the trail. She has decades of life ahead of her. She deserves an approach that builds her metabolism back up, not one that quietly hollows out her muscle while the scale changes.

The Live Light Hearted program is that approach. Over the course of the program we recalibrate the exact systems Ozempic tries to override from the outside — blood sugar, appetite, inflammation, nervous system tone, gut health, muscle — so your body starts producing its own GLP-1, its own insulin sensitivity, its own energy. You feel amazing not because a drug is muting your appetite, but because your biology is finally being fed what it has been asking for all along.

That is the difference between managed and well.

Let's Keep the Conversation Going

If something in this resonated with you, I'd love to keep the conversation going. Hit reply and tell me what's landing — or what question it's stirring up.

If you're a high achiever in your 40s or beyond who's starting to feel like your body isn't keeping pace with your ambition, my work might be exactly what you've been looking for. You can explore more or book a conversation with me — no pressure, just a real exchange.

---

This article is educational and is intended to support — not replace — the conversation with your healthcare provider. Always work with a qualified clinician before changing medications or starting a new health protocol.